SAI-CHING J YEUNG to Head and Neck Neoplasms
This is a "connection" page, showing publications SAI-CHING J YEUNG has written about Head and Neck Neoplasms.
Connection Strength
1.126
-
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors. Head Neck. 2024 03; 46(3):627-635.
Score: 0.323
-
Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer. 2021 02 15; 127(4):528-534.
Score: 0.259
-
Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review. Int J Mol Sci. 2023 Nov 30; 24(23).
Score: 0.080
-
Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors. BMC Cancer. 2021 Dec 06; 21(1):1304.
Score: 0.070
-
Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers. Head Neck. 2021 02; 43(2):613-621.
Score: 0.065
-
Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 2020 12 01; 126(23):5124-5136.
Score: 0.064
-
Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review. Head Neck. 2019 11; 41(11):4036-4050.
Score: 0.060
-
Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep. 2018 06 08; 8(1):8789.
Score: 0.055
-
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One. 2017; 12(7):e0180396.
Score: 0.052
-
Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017 06; 39(6):1195-1204.
Score: 0.051
-
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients. BMC Genet. 2016 Feb 13; 17:40.
Score: 0.047